Monday, July 6, 2020

Burton pharma giant partners with Swiss company to combat potentially fatal infections

Burton-based pharmaceutical and services giant Clinigen Group and Basilea Pharmaceutica International, a Swiss pharmaceutical company focused on providing innovative pharmaceutical hospital products, have initiated a Managed Access program for isavuconazole to treat patients with invasive fungal infections in those European countries where isavuconazole has been approved but is not yet commercially available.

Isavuconazole is an intravenous and oral triazole antifungal indicated for the treatment of adult patients with invasive aspergillosis and adult patients with mucormycosis for whom amphotericin B is inappropriate.

Isavuconazole received U.S FDA approval in March 2015 and European Marketing Authorisation in October 2015, and is commercially available in the U.S and in certain key European Union (EU) countries, including Germany and the UK. Isavuconazole is not yet commercially available in all EU countries. Outside the U.S and EU, isavuconazole is an investigational product not approved for commercial use.

The access program will be run by Clinigen’s Idis Managed Access (MA) division and will enable patients with serious fungal infections in those EU states where isavuconazole is not yet commercially available as well as Iceland, Liechtenstein and Norway, to access isavuconazole via their physician.

Access to isavuconazole will be provided by Idis MA following a physician request for individual patients who meet the established eligibility criteria.

Steve Glass, group managing director of Clinigen, said: “Invasive fungal infections pose a fatal threat to immuno-compromised patients. It is therefore crucial that new treatment options like isavuconazole are made available and can be accessed by those who need it at the first possible opportunity. As partners to Basilea, Idis MA will leverage its European distribution network and regulatory expertise to deliver this important medicine to individual patients, wherever they are located in Europe”.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 lockdown having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £33.60 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.






Latest news

Broadmarsh retail partnership enters compulsory liquidation

The partnership redeveloping Nottingham's Broadmarsh shopping centre has been wound up. Petitions have also been presented against related companies and these have also entered compulsory...

Staton Young swoop for ‘The Post House’ in Derby

Staton Young Group has purchased ‘The Post House’ on Victoria Street, Derby for an undisclosed sum through FHP. In a record-breaking deal, Staton Young secured a...

East Midlands businesses’ cash generation worryingly low heading into COVID-19 crisis

East Midlands businesses’ cash generation has stayed worryingly low heading into the cash crunch triggered by the COVID-19 pandemic, shows a new study by...

University of Lincoln research predicts digital future for law firm

Students participating in the University of Lincoln’s Graduate Skills Builder programme have recently submitted a report following a market research project to a regional...

Record year continues at GIC

A Lincolnshire packaging machinery manufacturer’s strong start to 2020 has continued this month, with the company sending a record number of machines out of...

Related news

£500k funding boost for Kegworth village centre

Kegworth village centre is set for a major revamp after £500,000 of funding was secured this week by North West Leicestershire District Council (NWLDC). The...

Broadmarsh retail partnership enters compulsory liquidation

The partnership redeveloping Nottingham's Broadmarsh shopping centre has been wound up. Petitions have also been presented against related companies and these have also entered compulsory...

Staton Young swoop for ‘The Post House’ in Derby

Staton Young Group has purchased ‘The Post House’ on Victoria Street, Derby for an undisclosed sum through FHP. In a record-breaking deal, Staton Young secured a...

East Midlands businesses’ cash generation worryingly low heading into COVID-19 crisis

East Midlands businesses’ cash generation has stayed worryingly low heading into the cash crunch triggered by the COVID-19 pandemic, shows a new study by...

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close